Icon

Juluca - (Eq 50 mg; Eq 25 mg base, Tablet, Oral)

Dolutegravir Sodium and Rilpivirine VIIV Healthcare
Eq 50 mg; Eq 25 mg base, Tablet, Oral
Less Than $1000 mn
Less Than 5
Less Than 5
More Than 5
Less Than 5
None None
JULUCA is a prescription medicine that is used to treat Human Immunodeficiency Virus-1 (HIV-1) infection in adults.
Yes
***** ** ***. ***** ***** * **** ** ** ******* '***, '*** *** *** *********. ** ****** **** **** ***** ****** ** *** ****. ********* ** *** (**** **********) *** ******, ******** ****** ****** ** ****. ********, **** ** *** ******** *** ****** ****** ******* ****** ****. *****, ***** ***** * **** ** ** ******* '***, '*** *** *** *********.
Juluca Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7
***** *** ********* **** *** **** *** *** ********* **** *** ******* *******
***** *** ********* *** ********* *** ********* *** ********* *** ********* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
***** *** \ ********* *** **, **** ******* ********* ******** ******* *** **** *** *** ****
***** ** \ ** *** **, **** ******* **** ******* *** **** *** *** ****
  1. *** **, **** : ***** ******** **** ********** ***** **'* **** ** ****** ** ******* ’*** *** ’***
  2. *** **, **** : **** ********* ***** * **** ******* ***** ** ******* ’*** *** ’***
  3. *** **, **** : ***** ******** **** ********** ***** **'* **** ** ****** ** ******* ’*** *** ’***
  4. *** **, **** : **** ********* ***** * **** ******* ***** ** ******* ’*** *** ’***
  5. *** **, **** : **** ********** ******* **** ***** *** **** ***** ********** *** **-***** **** **** *****'* ********.
  6. *** **, **** : **** ********** *** ***** ******* ********** ** ******* *****

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.